Ally Financial’s Edwards Lifesciences EW Stock Holding History

Ally Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04M	Buy	+13,000	New	+$1.07M	0.13%	109
2025 Q2	–	Sell	-15,000	Closed	-$1.09M	–	110
2025 Q1	$1.09M	Hold	15,000	–	–	0.12%	95
2024 Q4	$1.11M	Hold	15,000	–	–	0.14%	89
2024 Q3	$990K	Buy	+15,000	New	+$1.09M	0.12%	98
2024 Q2	–	Sell	-6,000	Closed	-$573K	–	119
2024 Q1	$573K	Hold	6,000	–	–	0.08%	104
2023 Q4	$458K	Hold	6,000	–	–	0.06%	98
2023 Q3	$416K	Buy	+6,000	New	+$482K	0.06%	105
2014 Q2	–	Sell	-210,000	Closed	-$2.6M	–	132
2014 Q1	$2.6M	Buy	210,000 +150,000	+250%	+$1.73M	0.28%	118
2013 Q4	$658K	Buy	+60,000	New	+$676K	0.07%	121

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ally Financial's EW Position: Q1 2026 in Review

Ally Financial opened a new position in Edwards Lifesciences (EW) in Q1 2026: 13,000 shares worth $1.04M. The stake represents 0.13% of the portfolio and ranks #109 among its holdings. This is a return to the name: Ally Financial previously reported a position in EW as recently as Q1 2025.

Ally Financial first reported a position in EW in Q4 2013 and has held it in 9 quarters since. The position peaked at $2.6M in Q1 2014. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Ally Financial held 13,000 shares of Edwards Lifesciences worth $1.04M as of Q1 2026.
Edwards Lifesciences was a new Ally Financial position in Q1 2026.
Edwards Lifesciences made up 0.13% of Ally Financial's portfolio in Q1 2026, its #109 holding.
Ally Financial first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 9 quarters since.
Ally Financial's Edwards Lifesciences position peaked at $2.6M in Q1 2014.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.